J. B. Chemicals & Pharmaceuticals Statistics

Total Valuation

J. B. Chemicals & Pharmaceuticals has a market cap or net worth of INR 294.31 billion. The enterprise value is 291.14 billion.

Market Cap	294.31B
Enterprise Value	291.14B

Important Dates

The next estimated earnings date is Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	Aug 14, 2024

Share Statistics

J. B. Chemicals & Pharmaceuticals has 155.31 million shares outstanding. The number of shares has increased by 0.87% in one year.

Current Share Class	n/a
Shares Outstanding	155.31M
Shares Change (YoY)	+0.87%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	23.88%
Float	71.07M

Valuation Ratios

The trailing PE ratio is 49.31 and the forward PE ratio is 37.44. J. B. Chemicals & Pharmaceuticals's PEG ratio is 1.65.

PE Ratio	49.31
Forward PE	37.44
PS Ratio	7.92
PB Ratio	9.16
P/TBV Ratio	16.38
P/FCF Ratio	43.77
P/OCF Ratio	n/a
PEG Ratio	1.65

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.17, with an EV/FCF ratio of 43.30.

EV / Earnings	47.64
EV / Sales	7.84
EV / EBITDA	30.17
EV / EBIT	35.92
EV / FCF	43.30

Financial Position

The company has a current ratio of 3.08, with a Debt / Equity ratio of 0.03.

Current Ratio	3.08
Quick Ratio	1.98
Debt / Equity	0.03
Debt / EBITDA	0.10
Debt / FCF	0.15
Interest Coverage	28.02

Financial Efficiency

Return on equity (ROE) is 20.62% and return on invested capital (ROIC) is 15.64%.

Return on Equity (ROE)	20.62%
Return on Assets (ROA)	12.94%
Return on Capital (ROIC)	15.64%
Revenue Per Employee	6.99M
Profits Per Employee	1.15M
Employee Count	5,311
Asset Turnover	0.95
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+30.48%
50-Day Moving Average	1,822.35
200-Day Moving Average	1,805.75
Relative Strength Index (RSI)	63.45
Average Volume (20 Days)	3,498

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, J. B. Chemicals & Pharmaceuticals had revenue of INR 37.11 billion and earned 6.11 billion in profits. Earnings per share was 38.43.

Revenue	37.11B
Gross Profit	24.27B
Operating Income	8.11B
Pretax Income	8.25B
Net Income	6.11B
EBITDA	9.65B
EBIT	8.11B
Earnings Per Share (EPS)	38.43

Full Income Statement

Balance Sheet

The company has 4.17 billion in cash and 1.00 billion in debt, giving a net cash position of 3.17 billion or 20.39 per share.

Cash & Cash Equivalents	4.17B
Total Debt	1.00B
Net Cash	3.17B
Net Cash Per Share	20.39
Equity (Book Value)	32.12B
Book Value Per Share	206.83
Working Capital	12.91B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.45 billion and capital expenditures -726.43 million, giving a free cash flow of 6.72 billion.

Operating Cash Flow	7.45B
Capital Expenditures	-726.43M
Free Cash Flow	6.72B
FCF Per Share	43.29

Full Cash Flow Statement

Margins

Gross margin is 65.40%, with operating and profit margins of 21.84% and 16.47%.

Gross Margin	65.40%
Operating Margin	21.84%
Pretax Margin	22.23%
Profit Margin	16.47%
EBITDA Margin	26.00%
EBIT Margin	21.84%
FCF Margin	18.12%

Dividends & Yields

This stock pays an annual dividend of 13.50, which amounts to a dividend yield of 0.71%.

Dividend Per Share	13.50
Dividend Yield	0.71%
Dividend Growth (YoY)	38.03%
Years of Dividend Growth	1
Payout Ratio	31.11%
Buyback Yield	-0.87%
Shareholder Yield	-0.15%
Earnings Yield	2.03%
FCF Yield	2.28%

Dividend Details

Stock Splits

The last stock split was on September 18, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 18, 2023
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a